CSL Behring’s recombinant factor development pipeline is built on its strength in protein research and development and scientific expertise in bleeding disorders
CSL Behring is committed to the future research and development of coagulation therapies.
Diagnosis & Treatment Guidelines
The following list includes current CSL Behring studies. Please visit ClinicalTrials.gov for details about each clinical trial.